carnitine has been researched along with Anemia in 50 studies
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "L-carnitine is an amino acid derivative that is thought to be helpful for treating renal anemia in hemodialysis patients." | 9.12 | Effect of L-carnitine supplementation on renal anemia in patients on hemodialysis: a meta-analysis. ( Deng, J; Ou, J; Xie, Z; Xue, C; Zhu, Y, 2021) |
| "Carnitine supplementation in hemodialyzed patients was studied in a double-blinded, randomized, controlled trial in order to elucidate the effect of intravenous carnitine on renal anemia in patients treated with recombinant human erythropoietin (rHuEPO)." | 9.09 | Anemia and carnitine supplementation in hemodialyzed patients. ( Heinz-Peer, G; Hörl, WH; Kletzmayr, J; Kovarik, J; Legenstein, E; Leitha, T; Mayer, G, 1999) |
| "To demonstrate whether L-carnitine treatment could further improve the anemia in dialyzed patients under recombinant human erythropoietin (r-HuEPO) therapy, leading to a reduction in r-HuEPO requirements, L-carnitine (1 g intravenously after every dialysis session) was administered for 6 months to a group of 13 patients; the results were compared with data from a placebo control group (N = 11)." | 9.08 | L-carnitine effects on anemia in hemodialyzed patients treated with erythropoietin. ( Labonia, WD, 1995) |
| "Here, I present the effects of levocarnitine on renal anemia in hemodialysis patients with carnitine deficiency, focusing on the effect on dose reduction in erythropoiesis-stimulating agents and the influence on erythropoiesis resistance index." | 8.98 | Effects of Levocarnitine on Cardiac Function and Renal Anemia in Hemodialysis Patients. ( Higuchi, T, 2018) |
| "Carnitine deficiency was defined as a free carnitine level of less than 40 micromol/L." | 5.34 | Association of carnitine deficiency in Indian continuous ambulatory peritoneal dialysis patients with anemia, erythropoietin use, residual renal function, and diabetes mellitus. ( Abraham, G; Ashok, BS; Baben, B; Jayanthi, V; Leslie, N; Ramalakshmi, S, 2007) |
| "L-carnitine is an amino acid derivative that is thought to be helpful for treating renal anemia in hemodialysis patients." | 5.12 | Effect of L-carnitine supplementation on renal anemia in patients on hemodialysis: a meta-analysis. ( Deng, J; Ou, J; Xie, Z; Xue, C; Zhu, Y, 2021) |
| "Carnitine supplementation in hemodialyzed patients was studied in a double-blinded, randomized, controlled trial in order to elucidate the effect of intravenous carnitine on renal anemia in patients treated with recombinant human erythropoietin (rHuEPO)." | 5.09 | Anemia and carnitine supplementation in hemodialyzed patients. ( Heinz-Peer, G; Hörl, WH; Kletzmayr, J; Kovarik, J; Legenstein, E; Leitha, T; Mayer, G, 1999) |
| "To demonstrate whether L-carnitine treatment could further improve the anemia in dialyzed patients under recombinant human erythropoietin (r-HuEPO) therapy, leading to a reduction in r-HuEPO requirements, L-carnitine (1 g intravenously after every dialysis session) was administered for 6 months to a group of 13 patients; the results were compared with data from a placebo control group (N = 11)." | 5.08 | L-carnitine effects on anemia in hemodialyzed patients treated with erythropoietin. ( Labonia, WD, 1995) |
| "Here, I present the effects of levocarnitine on renal anemia in hemodialysis patients with carnitine deficiency, focusing on the effect on dose reduction in erythropoiesis-stimulating agents and the influence on erythropoiesis resistance index." | 4.98 | Effects of Levocarnitine on Cardiac Function and Renal Anemia in Hemodialysis Patients. ( Higuchi, T, 2018) |
| "Carnitine deficiency contributes to developing various pathological conditions, such as cardiac dysfunction, muscle weakness, and erythropoietin-resistant anemia in patients undergoing hemodialysis." | 3.96 | Association between carnitine deficiency and the erythropoietin resistance index in patients undergoing peritoneal dialysis: a cross-sectional observational study. ( Aomatsu, A; Hirai, K; Ishii, H; Ito, K; Kaneko, S; Kitano, T; Matsuyama, M; Minato, S; Miyazawa, H; Morino, J; Morishita, Y; Mutsuyoshi, Y; Ookawara, S; Shindo, M; Ueda, Y; Yanai, K, 2020) |
| "Our data revealed that longer acyl chain length significantly predicts poorer physical function and worsened anemia, and this data supports our proposed mechanism, which may lead to increased understanding of altered carnitine metabolism in hemodialysis patients." | 3.78 | Altered carnitine metabolism in dialysis patients with reduced physical function may be due to dysfunctional fatty acid oxidation. ( Carder, J; Connery, GC; Hoppel, C; Murphy, WJ; Spry, L; Steiber, A, 2012) |
| "To evaluate the effects of L-carnitine oral supplementation on anemia and cardiac function in patients on maintenance hemodialysis (HD), we studied 55 adult chronic HD patients at our center during the period from January 2006 to June 2006 and divided them into two groups; a group of 20 patients who received 1500 mg/day oral L-carnitine and a control group of 35 patients." | 3.76 | The role of oral L-carnitine therapy in chronic hemodialysis patients. ( Sabry, AA, 2010) |
| "L-carnitine is an important factor in fatty acid metabolism, and carnitine deficiency is common in dialysis patients." | 2.94 | Effects of L-Carnitine Supplementation in Patients Receiving Hemodialysis or Peritoneal Dialysis. ( Ichikawa, S; Io, H; Kanda, R; Kuwasawa-Iwasaki, M; Muto, M; Nakata, J; Nohara, N; Suzuki, Y; Tomino, Y; Wakabayashi, K, 2020) |
| "Methylmalonic aciduria (MMA) is a common one of the congenital disorders of organic acids metabolism." | 2.73 | [Clinical studies on fifty-seven Chinese patients with combined methylmalonic aciduria and homocysteinemia]. ( Dong, JH; Jiang, YW; Liu, P; Qin, J; Song, JQ; Wang, LF; Wu, XR; Yan, R; Yang, YL; Zhang, Y; Zhang, YH, 2007) |
| "Carnitine is an amino acid derivative that has a key role in the regulation of fatty acid metabolism and ATP formation." | 2.43 | The use of levo-carnitine in children with renal disease: a review and a call for future studies. ( Belay, B; Esteban-Cruciani, N; Kaskel, FJ; Walsh, CA, 2006) |
| "Anemia is common in chronic renal failure." | 2.42 | The management of anemia in pediatric peritoneal dialysis patients. Guidelines by an ad hoc European committee. ( Schröder, CH, 2003) |
| "In patients with chronic renal failure, not yet undergoing hemodialysis (HD), plasma acylcarnitines accumulate in part due to a decreased renal clearance of esterified carnitine moieties." | 2.42 | Carnitine replacement in end-stage renal disease and hemodialysis. ( Amato, A; Benatti, P; Brass, EP; Calvani, M; D'Iddio, S; Giordano, V; Koverech, A; Mancinelli, A, 2004) |
| " The active vitamin D metabolites alfacalcidol and calcitriol may, under some circumstances, improve anaemia and reduce epoetin dosage requirements." | 2.40 | Is there a role for adjuvant therapy in patients being treated with epoetin? ( Hörl, WH, 1999) |
| "Carnitine deficiency was defined as a free carnitine level of less than 40 micromol/L." | 1.34 | Association of carnitine deficiency in Indian continuous ambulatory peritoneal dialysis patients with anemia, erythropoietin use, residual renal function, and diabetes mellitus. ( Abraham, G; Ashok, BS; Baben, B; Jayanthi, V; Leslie, N; Ramalakshmi, S, 2007) |
| "Carnitor use for carnitine deficiency in chronic renal failure is a multidisciplinary management issue." | 1.30 | Use of Carnitor for Epogen resistant anemia. ( Simard, JC, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (4.00) | 18.7374 |
| 1990's | 13 (26.00) | 18.2507 |
| 2000's | 24 (48.00) | 29.6817 |
| 2010's | 8 (16.00) | 24.3611 |
| 2020's | 3 (6.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaneko, S | 1 |
| Hirai, K | 1 |
| Morino, J | 1 |
| Minato, S | 1 |
| Yanai, K | 1 |
| Mutsuyoshi, Y | 1 |
| Ishii, H | 1 |
| Matsuyama, M | 1 |
| Kitano, T | 1 |
| Shindo, M | 1 |
| Aomatsu, A | 1 |
| Miyazawa, H | 1 |
| Ueda, Y | 1 |
| Ito, K | 1 |
| Ookawara, S | 1 |
| Morishita, Y | 1 |
| Kuwasawa-Iwasaki, M | 1 |
| Io, H | 1 |
| Muto, M | 1 |
| Ichikawa, S | 1 |
| Wakabayashi, K | 1 |
| Kanda, R | 1 |
| Nakata, J | 1 |
| Nohara, N | 1 |
| Tomino, Y | 1 |
| Suzuki, Y | 1 |
| Zhu, Y | 1 |
| Xue, C | 1 |
| Ou, J | 1 |
| Xie, Z | 1 |
| Deng, J | 1 |
| Kamei, D | 1 |
| Tsuchiya, K | 1 |
| Nitta, K | 1 |
| Mineshima, M | 1 |
| Akiba, T | 1 |
| Higuchi, T | 1 |
| Hayashi, K | 1 |
| Hyo, R | 1 |
| Takeuchi, A | 1 |
| Tokunaga, H | 1 |
| Nakanishi, H | 1 |
| Wada, H | 1 |
| Sugihara, T | 1 |
| Nemati, A | 1 |
| Moghadam, RA | 1 |
| Mazani, M | 1 |
| Darvishi, A | 1 |
| Macciò, A | 1 |
| Gramignano, G | 1 |
| Madeddu, C | 1 |
| Cruciani, RA | 1 |
| Dvorkin, E | 1 |
| Homel, P | 1 |
| Culliney, B | 1 |
| Malamud, S | 1 |
| Lapin, J | 1 |
| Portenoy, RK | 1 |
| Esteban-Cruciani, N | 2 |
| Reuter, SE | 2 |
| Faull, RJ | 2 |
| Ranieri, E | 1 |
| Evans, AM | 2 |
| Sabry, AA | 1 |
| Bonomini, M | 2 |
| Zammit, V | 1 |
| Pusey, CD | 2 |
| De Vecchi, A | 1 |
| Arduini, A | 2 |
| Murphy, WJ | 1 |
| Steiber, A | 1 |
| Connery, GC | 1 |
| Carder, J | 1 |
| Spry, L | 1 |
| Hoppel, C | 1 |
| Debska-Slizień, A | 1 |
| Owczarzak, A | 1 |
| Kunicka, D | 1 |
| Lysiak-Szydłowska, W | 1 |
| Rutkowski, B | 1 |
| Eknoyan, G | 1 |
| Latos, DL | 1 |
| Lindberg, J | 1 |
| Schröder, CH | 2 |
| Golper, TA | 1 |
| Goral, S | 1 |
| Becker, BN | 1 |
| Langman, CB | 1 |
| Wanic-Kossowska, M | 1 |
| Kurzawska-Firlej, D | 1 |
| Kaźmierski, M | 1 |
| Czekalski, S | 1 |
| Maeda, H | 1 |
| Hirakata, H | 1 |
| Calvani, M | 1 |
| Benatti, P | 1 |
| Mancinelli, A | 1 |
| D'Iddio, S | 1 |
| Giordano, V | 1 |
| Koverech, A | 1 |
| Amato, A | 1 |
| Brass, EP | 1 |
| Handelman, GJ | 1 |
| Belay, B | 1 |
| Walsh, CA | 1 |
| Kaskel, FJ | 1 |
| Clutterbuck, EJ | 1 |
| Laffan, MA | 1 |
| Verrina, E | 1 |
| Caruso, U | 1 |
| Calevo, MG | 1 |
| Emma, F | 1 |
| Sorino, P | 1 |
| De Palo, T | 1 |
| Lavoratti, G | 1 |
| Turrini Dertenois, L | 1 |
| Cassanello, M | 1 |
| Cerone, R | 1 |
| Perfumo, F | 1 |
| Ramalakshmi, S | 1 |
| Baben, B | 1 |
| Ashok, BS | 1 |
| Jayanthi, V | 1 |
| Leslie, N | 1 |
| Abraham, G | 1 |
| Zhang, Y | 1 |
| Song, JQ | 1 |
| Liu, P | 1 |
| Yan, R | 1 |
| Dong, JH | 1 |
| Yang, YL | 1 |
| Wang, LF | 1 |
| Jiang, YW | 1 |
| Zhang, YH | 1 |
| Qin, J | 1 |
| Wu, XR | 1 |
| Labonia, WD | 1 |
| Kavadias, D | 1 |
| Fourtounas, C | 1 |
| Tsouchnikas, J | 1 |
| Barboutis, K | 1 |
| Matsumura, M | 1 |
| Hatakeyama, S | 1 |
| Koni, I | 1 |
| Mabuchi, H | 1 |
| Muramoto, H | 1 |
| Boran, M | 1 |
| Dalva, I | 1 |
| Gönenç, F | 1 |
| Cetin, S | 1 |
| Thompson, CH | 1 |
| Irish, AB | 1 |
| Kemp, GJ | 1 |
| Taylor, DJ | 1 |
| Radda, GK | 1 |
| Macdougall, IC | 1 |
| Kletzmayr, J | 1 |
| Mayer, G | 1 |
| Legenstein, E | 1 |
| Heinz-Peer, G | 1 |
| Leitha, T | 1 |
| Hörl, WH | 3 |
| Kovarik, J | 1 |
| Simard, JC | 1 |
| Mantovani, LG | 1 |
| Belisari, A | 1 |
| Bommer, J | 1 |
| Azzadin, A | 1 |
| Wollny, T | 1 |
| Pawlak, R | 1 |
| Malyszko, JS | 1 |
| Malyszko, J | 1 |
| Myśliwiec, M | 1 |
| Buczko, W | 1 |
| Lilien, MR | 1 |
| Duran, M | 1 |
| Quak, JM | 1 |
| Frankhuisen, JJ | 1 |
| Matsumoto, Y | 1 |
| Amano, I | 1 |
| Hirose, S | 1 |
| Tsuruta, Y | 1 |
| Hara, S | 1 |
| Murata, M | 1 |
| Imai, T | 1 |
| Kawabata, M | 1 |
| Kasuga, S | 1 |
| Hara, H | 1 |
| Suyama, S | 1 |
| Moriyama, K | 1 |
| Takabatake, T | 1 |
| Hurot, JM | 1 |
| Cucherat, M | 1 |
| Haugh, M | 1 |
| Fouque, D | 1 |
| Cianciaruso, B | 1 |
| Torraca, S | 1 |
| De Blasio, A | 1 |
| Fiorillo, M | 1 |
| Marino, R | 1 |
| Kooistra, MP | 1 |
| Struyvenberg, A | 1 |
| van Es, A | 1 |
| Tanphaichitr, V | 2 |
| Broquist, HP | 2 |
| Horne, DW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Impact of Hemodialysis on Plasma Carnitine Levels in Patients With End Stage Renal Disease[NCT05817799] | Phase 2/Phase 3 | 83 participants (Anticipated) | Interventional | 2023-01-01 | Recruiting | ||
| Carnitine Deficiency and Benefits of Its Supplementation in Pediatric Hemodialysis Patients[NCT05948124] | Early Phase 1 | 40 participants (Anticipated) | Interventional | 2023-08-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
16 reviews available for carnitine and Anemia
| Article | Year |
|---|---|
Effect of L-carnitine supplementation on renal anemia in patients on hemodialysis: a meta-analysis.
Topics: Anemia; Carnitine; Dietary Supplements; Humans; Renal Dialysis; Renal Insufficiency, Chronic | 2021 |
Effects of Levocarnitine on Cardiac Function and Renal Anemia in Hemodialysis Patients.
Topics: Anemia; Cardiomyopathies; Carnitine; Heart; Hematinics; Humans; Hyperammonemia; Kidney Failure, Chro | 2018 |
Pharmacological use of L-carnitine in uremic anemia: has its full potential been exploited?
Topics: Anemia; Animals; Carnitine; Erythrocytes; Humans; Randomized Controlled Trials as Topic; Renal Dialy | 2011 |
Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder. National Kidney Foundation Carnitine Consensus Conference.
Topics: Anemia; Carnitine; Fatigue; Homeostasis; Humans; Hypotension; Kidney; Kidney Failure, Chronic; Renal | 2003 |
The management of anemia in pediatric peritoneal dialysis patients. Guidelines by an ad hoc European committee.
Topics: Anemia; Carnitine; Child; Erythropoietin; Europe; Humans; Iron; Kidney Failure, Chronic; Practice Gu | 2003 |
L-carnitine treatment of anemia.
Topics: Anemia; Carnitine; Erythrocytes; Humans; Kidney Failure, Chronic; Renal Dialysis | 2003 |
[Anemia in chronic renal failure. The role of L-carnitine in the treatment of anemia of hemodialyzed patients].
Topics: Anemia; Carnitine; Erythropoiesis; Erythropoietin; Humans; Kidney Failure, Chronic; Platelet Aggrega | 2003 |
[Hyporesponsiveness to recombinant human erythropoietin therapy in anemic patients on hemodialysis].
Topics: Aluminum; Anemia; Angiotensin-Converting Enzyme Inhibitors; Carnitine; Chronic Disease; Drug Resista | 2004 |
Carnitine replacement in end-stage renal disease and hemodialysis.
Topics: Anemia; Cardiomyopathies; Carnitine; Homeostasis; Humans; Kidney Failure, Chronic; Renal Dialysis | 2004 |
Debate forum: carnitine supplements have not been demonstrated as effective in patients on long-term dialysis therapy.
Topics: Anemia; Carnitine; Drug Resistance; Erythropoietin; Fatigue; Hypotension; Randomized Controlled Tria | 2006 |
The use of levo-carnitine in children with renal disease: a review and a call for future studies.
Topics: Anemia; Carnitine; Child; Dyslipidemias; Humans; Kidney Diseases; Kidney Failure, Chronic; Stereoiso | 2006 |
L-carnitine supplementation in the dialysis population: are Australian patients missing out?
Topics: Anemia; Ascorbic Acid; Carnitine; Follow-Up Studies; Humans; Kidney Failure, Chronic; Prevalence; Re | 2008 |
Meeting the challenges of a new millennium: optimizing the use of recombinant human erythropoietin.
Topics: Anemia; Ascorbic Acid; Carnitine; Clinical Trials as Topic; Cytokines; Drug Administration Schedule; | 1998 |
Is there a role for adjuvant therapy in patients being treated with epoetin?
Topics: Androgens; Anemia; Angiotensin-Converting Enzyme Inhibitors; Ascorbic Acid; Carnitine; Cytokines; Er | 1999 |
Effects of L-carnitine supplementation in maintenance hemodialysis patients: a systematic review.
Topics: Anemia; Carnitine; Erythropoietin; Humans; Lipids; Randomized Controlled Trials as Topic; Renal Dial | 2002 |
Adjunctive therapy in anaemia management.
Topics: Anemia; Carnitine; Dietary Supplements; Erythropoietin; Humans; Iron; Kidney Failure, Chronic; Oxida | 2002 |
10 trials available for carnitine and Anemia
| Article | Year |
|---|---|
Effects of L-Carnitine Supplementation in Patients Receiving Hemodialysis or Peritoneal Dialysis.
Topics: Anemia; Cardiomyopathies; Carnitine; Dietary Supplements; Female; Heart; Humans; Hyperammonemia; Jap | 2020 |
Effect of L-carnitine and conjugated linoleic acid supplements on haemoglobin levels and haptoglobin genotype in chronic kidney disease.
Topics: Adult; Anemia; C-Reactive Protein; Carnitine; Dietary Supplements; Ferritins; Genotype; Haptoglobins | 2019 |
L-carnitine supplementation in patients with advanced cancer and carnitine deficiency: a double-blind, placebo-controlled study.
Topics: Aged; Anemia; Carnitine; Dietary Supplements; Double-Blind Method; Female; Humans; Karnofsky Perform | 2009 |
Effect of carnitine supplementation on lipid profile and anemia in children on chronic dialysis.
Topics: Adolescent; Anemia; Carnitine; Child; Dietary Supplements; Erythropoietin; Hematocrit; Humans; Lipid | 2007 |
[Clinical studies on fifty-seven Chinese patients with combined methylmalonic aciduria and homocysteinemia].
Topics: Adolescent; Adult; Amino Acid Metabolism, Inborn Errors; Anemia; Carnitine; Child; Child, Preschool; | 2007 |
L-carnitine effects on anemia in hemodialyzed patients treated with erythropoietin.
Topics: Adult; Aged; Anemia; Carnitine; Erythropoietin; Female; Hematocrit; Humans; Iron; Male; Middle Aged; | 1995 |
Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Blood Urea Nitrogen; Carnitine; Centrifugation; Erythropoiet | 1996 |
Response to recombinant human erythropoietin (r-Hu EPO) and L-carnitine combination in patients with anemia of end-stage renal disease.
Topics: Anemia; Carnitine; Drug Therapy, Combination; Erythropoietin; Humans; Kidney Failure, Chronic; Recom | 1996 |
Anemia and carnitine supplementation in hemodialyzed patients.
Topics: Adult; Aged; Anemia; Carnitine; Double-Blind Method; Erythrocyte Aging; Erythrocyte Count; Erythropo | 1999 |
Oral L-carnitine does not decrease erythropoietin requirement in pediatric dialysis.
Topics: Administration, Oral; Adolescent; Adult; Anemia; Carnitine; Child; Child, Preschool; Dose-Response R | 2000 |
24 other studies available for carnitine and Anemia
| Article | Year |
|---|---|
Association between carnitine deficiency and the erythropoietin resistance index in patients undergoing peritoneal dialysis: a cross-sectional observational study.
Topics: Aged; Anemia; Carnitine; Cross-Sectional Studies; Drug Resistance; Erythropoietin; Female; Humans; J | 2020 |
Association between resistance to erythropoiesis-stimulating agents and carnitine profile in patients on maintenance haemodialysis.
Topics: Adult; Aged; Anemia; Biomarkers; Carnitine; Chromatography, Liquid; Cross-Sectional Studies; Drug Re | 2018 |
[Case Report ; Levocarnitine supplementation has been ameliorated prolonged cytopenia of the patient after chemoradiotherapy].
Topics: Anemia; Bone Marrow; Carnitine; Chemoradiotherapy; Humans; Laryngeal Neoplasms; Male | 2016 |
Surprising results of a supportive integrated therapy in myelofibrosis.
Topics: Anemia; C-Reactive Protein; Cachexia; Carnitine; Celecoxib; Curcumin; Erythropoietin; Fatigue; Ferri | 2015 |
Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients.
Topics: Adult; Aged; Anemia; Carnitine; Cohort Studies; Dose-Response Relationship, Drug; Drug Resistance; E | 2009 |
The role of oral L-carnitine therapy in chronic hemodialysis patients.
Topics: Administration, Oral; Adult; Anemia; Carnitine; Chronic Disease; Dietary Supplements; Echocardiograp | 2010 |
Altered carnitine metabolism in dialysis patients with reduced physical function may be due to dysfunctional fatty acid oxidation.
Topics: Activities of Daily Living; Aged; Anemia; Carnitine; Cross-Sectional Studies; Erythrocytes; Erythrop | 2012 |
Plasma carnitine profile during chronic renal anemia treatment with recombinant human erythropoietin.
Topics: Adolescent; Adult; Aged; Anemia; Carnitine; Epoetin Alfa; Erythropoietin; Female; Ferritins; Hematin | 2003 |
Effect of L-carnitine administration on erythrocyte survival in haemodialysis patients.
Topics: Anemia; Carnitine; Cell Survival; Erythrocytes; Follow-Up Studies; Hematocrit; Humans; Randomized Co | 2006 |
II. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults.
Topics: Adult; Androgens; Anemia; Ascorbic Acid; Blood Cell Count; Blood Transfusion; Carnitine; Contraindic | 2006 |
III. Clinical practice recommendations for anemia in chronic kidney disease in children.
Topics: Adolescent; Androgens; Anemia; Ascorbic Acid; Blood Cell Count; Blood Transfusion; Carnitine; Child; | 2006 |
Association of carnitine deficiency in Indian continuous ambulatory peritoneal dialysis patients with anemia, erythropoietin use, residual renal function, and diabetes mellitus.
Topics: Adult; Aged; Anemia; Carnitine; Chi-Square Distribution; Diabetes Mellitus; Erythropoietin; Female; | 2007 |
L-carnitine and erythropoietin requirements in hemodialysis patients.
Topics: Aged; Anemia; Carnitine; Erythropoietin; Humans; Kidney Failure, Chronic; Recombinant Proteins; Rena | 1996 |
The effect of propionyl L-carnitine on skeletal muscle metabolism in renal failure.
Topics: Adenosine Triphosphate; Anemia; Carnitine; Exercise; Female; Hemoglobins; Humans; Kidney Failure, Ch | 1997 |
Use of Carnitor for Epogen resistant anemia.
Topics: Aged; Aged, 80 and over; Anemia; Carnitine; Drug Resistance; Epoetin Alfa; Erythropoietin; Hematinic | 1999 |
L-carnitine use in hemodialyzed patients.
Topics: Anemia; Carnitine; Hematocrit; Humans; Renal Dialysis | 1999 |
Saving erythropoietin by administering L-carnitine?
Topics: Anemia; Carnitine; Erythrocytes; Erythropoietin; Humans; Recombinant Proteins; Renal Dialysis; Sodiu | 1999 |
L-Carnitine effects on anemia in uremic rats treated with erythropoietin.
Topics: Anemia; Animals; Carnitine; Erythropoietin; Hematocrit; Male; Rats; Rats, Wistar; Recombinant Protei | 1999 |
Effects of L-carnitine supplementation on renal anemia in poor responders to erythropoietin.
Topics: Adult; Aged; Anemia; Carnitine; Dietary Supplements; Erythrocytes; Erythropoietin; Female; Hematocri | 2001 |
Erythropoietin-resistant refractory renal anemia: effects of oral L-carnitine supplementation.
Topics: Administration, Oral; Aged; Anemia; Carnitine; Disease Progression; Drug Resistance; Erythropoietin; | 2001 |
Carnitine as adjuvant therapy in the management of renal anemia.
Topics: Anemia; Carnitine; Drug Resistance; Erythropoietin; Humans; Kidney Failure, Chronic; Uremia | 2002 |
The response to recombinant human erythropoietin in patients with the anemia of end-stage renal disease is correlated with serum carnitine levels.
Topics: Anemia; Carnitine; Dose-Response Relationship, Drug; Erythropoietin; Humans; Kidney Failure, Chronic | 1991 |
Lysine deficiency in the rat: concomitant impairement in carnitine biosynthesis.
Topics: Anemia; Animals; Blood Proteins; Body Weight; Carnitine; Deficiency Diseases; Dietary Proteins; Eryt | 1973 |
Lysine, a precursor of carnitine in the rat.
Topics: Anemia; Animals; Blood Proteins; Body Weight; Carbon Isotopes; Carnitine; Chromatography, Ion Exchan | 1971 |